1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

ASH: Two Immunochemotherapy Regimens With Rituximab for Newly Diagnosed … – Cancer Network

December 15, 2011Monoclonal Anti-CD20 Antibodiesadmin

ASH: Two Immunochemotherapy Regimens With Rituximab for Newly Diagnosed ...
Cancer Network
The 554 patients enrolled had bulky FL—stage II and higher, and had not received any prior treatment—and were randomized to either the CHOP-R arm, CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisone) and six doses of ...

Post navigation

← FDA Clearance for Presage(R) ST2 Assay for Patients with Heart Failure – MarketWatch (press release) Bristol-Myers Squibb Booked a New High – TradersHuddle.com →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos